Call to tighten up value for money appraisals of new drugs in England

The body that appraises the clinical and cost effectiveness of new drugs in England would do well to take a leaf out of its sister organizations' books in Wales and Scotland, says an editorial in the Drug and Therapeutics Bulletin.